-
042022.02
Dewpoint Therapeutics Announces Completion of $150 Million Series C FinancingDewpoint Therapeutics Announces Completion of $150 Million Series C Financing (prnewswire.com)
2022-02-04
MORE -
112022.01
Maze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision MediMaze Therapeutics Announces $190 Million Financing to Support the Advancement of Nine Precision Medicine Programs and Compass Platform for Genetically Defined Diseases | Business | thefacts.com
2022-01-11
MORE -
032021.11
Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell ImmunothShoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunotherapies (prnewswire.com)
2021-11-03
MORE -
252021.10
ReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD ProgramsReCode Scores $80 Million to Advance mRNA-Based Cystic Fibrosis, PCD Programs | BioSpace
2021-10-25
MORE -
252021.10
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the ClinicImmunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline into the Clinic and Expand Single Cell Analysis Drug Development Platform for Immuno-Oncology and Other Diseases (prnewswire.com)
2021-10-25
MORE -
062021.08
Sonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate theSonoma Biotherapeutics Raises $265 Million in an Oversubscribed Series B Financing to Translate the Promise of Cell Therapy into Curative Medicines for Autoimmune and Other Inflammatory Diseases | Business Wire
2021-08-06
MORE -
012021.07
Elevation Oncology Announces Pricing of Initial Public OfferingElevation Oncology Announces Pricing of Initial Public Offering (prnewswire.com)
2021-07-01
MORE -
132021.04
Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer TherAccent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins | Business Wire
2021-04-13
MORE -
132021.04
Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B FinancingSilverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing | Business Wire
2021-04-13
MORE -
132021.04
Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B FinancingAkrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing | Business Wire
2021-04-13
MORE